Paediatric oncology information pack for general practitioners

J A James1, D J Harris, M G Mott

  • 1Bristol Royal Hospital for Sick Children.

Insights

A new information pack for general practitioners significantly improved the management of childhood cancer and enhanced communication between primary care and oncology units. This resource supports healthcare professionals caring for children with neoplastic diseases.

Area of Science:

  • Pediatric Oncology
  • General Practice
  • Healthcare Communication

Background:

  • Management of childhood cancer requires specialized knowledge.
  • Effective communication between pediatric oncology units and general practitioners is crucial for optimal patient care.
  • General practitioners (GPs) play a vital role in supporting children with neoplastic diseases and their families.

Purpose of the Study:

  • To develop and evaluate an information pack for general practitioners on paediatric oncology.
  • To assess the impact of the information pack on GP's ability to manage children with neoplastic disease.
  • To determine the effect of the information pack on communication between oncology units and GPs.

Main Methods:

  • Development of a comprehensive information pack for GPs.
  • Distribution of the information pack to a cohort of 60 general practitioners.
  • Evaluation of the pack's utility through feedback from participating GPs.

Main Results:

  • The information pack was found to be helpful by 100% of the surveyed general practitioners.
  • GPs reported improved confidence and ability in managing pediatric cancer patients and their families.
  • Enhanced communication and collaboration between oncology specialists and primary care physicians were observed.

Conclusions:

  • The developed information pack is an effective tool for supporting general practitioners in paediatric oncology.
  • Similar educational resources could be beneficial for GPs in other pediatric subspecialties.
  • Improving information dissemination can strengthen multidisciplinary care for children with cancer.

Related Concept Videos

Cancer Therapies02:49

Cancer Therapies

Cancer therapies are various modes of treatment, such as surgery, radiation therapy, and chemotherapy that are administered to cancer patients.
However, cancer treatments can pose several challenges, as therapies used to kill cancer cells are generally also toxic to normal cells. Moreover, cancer cells mutate rapidly and can develop resistance to chemical agents or radiation therapy. Besides, all types of cancer cells may not respond to the same therapy. Some cancer cells respond to one...
Combination Therapies and Personalized Medicine02:50

Combination Therapies and Personalized Medicine

Combining two or more treatment methods increases the life span of cancer patients while reducing damage to vital organs or tissue from the overuse of a single treatment. Combination therapy also targets different cancer-inducing pathways, thus reducing the chances of developing resistance to treatment.
The combination of the drug acetazolamide and sulforaphane is a good example of combination therapy to treat cancer. The cells in the interior of a large tumor often die due to the hypoxic and...
Nursing Ethical Principles II01:27

Nursing Ethical Principles II

Ethical principles are essential in guiding nurses to fulfill their responsibilities, focusing on the quality of nursing care and decision-making. These principles, including autonomy, beneficence, non-maleficence, justice, and fidelity, shape the ethical framework within healthcare settings.
Consider the following scenario, which illustrates how these principles are applied in the care of Mr. John, a fifty-year-old teacher diagnosed with metastatic liver cancer.
Initially, Mr. John's cancer...
Drug Dosing: Infants and Children01:29

Drug Dosing: Infants and Children

Pediatric patient dosages diverge from adults due to disparities in body surface area, total body water, and extracellular fluid per kilogram of body weight. The dosing regimen considers the variations in pharmacokinetics and pharmacology across distinct age groups, encompassing preterm newborns, infants, young children, older children, and adolescents. Calculation of pediatric patient doses is predicated on determining body surface area, which exhibits a superior correlation with the child's...
Pharmacokinetics in Pediatric Patients: Overview and Drug Absorption01:23

Pharmacokinetics in Pediatric Patients: Overview and Drug Absorption

Understanding the physiological differences in the pediatric population is crucial for effective pharmacotherapy. Neonates, infants, and children exhibit significant variations in gastric pH, gastric emptying time, intestinal transit time, and biliary function. These variations profoundly affect oral drug absorption, necessitating a nuanced approach to pediatric dosing.Neonates present with a unique physiological profile, having a gastric pH greater than 4 and faster and more irregular gastric...
Pharmacokinetics in Pediatric Patients: Drug Distribution01:17

Pharmacokinetics in Pediatric Patients: Drug Distribution

Drug distribution in the pediatric population exhibits unique challenges and considerations due to the physiological differences between children, particularly neonates and infants, and adults. A crucial aspect of pediatric pharmacology is understanding how these differences impact the pharmacokinetics of various drugs, necessitating age-specific dosing strategies to ensure efficacy and safety.Neonates and infants have a higher total body water content, ~75%–90% of their body weight, compared...